BINEX Co., Ltd. (KOSDAQ:053030)
South Korea · Delayed Price · Currency is KRW 7,850.00
-250.00 (-3.09%)
Jun 10, 2026, 3:30 PM KST
BINEX Market Cap
BINEX has a market cap or net worth of 257.97 billion as of June 10, 2026. Its market cap has decreased by -48.86% in one year.
Market Cap
257.97B
Enterprise Value
341.56B
Revenue
164.00B
Ranking
n/a
PE Ratio
n/a
Stock Price
7,850.00
Market Cap Chart
Since March 1, 2002, BINEX's market cap has increased from 25.29B to 257.97B, an increase of 920.19%. That is a compound annual growth rate of 10.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2026 | 257.97B | -45.93% |
| Dec 30, 2025 | 477.08B | -18.32% |
| Dec 30, 2024 | 584.09B | 111.03% |
| Dec 28, 2023 | 276.77B | -22.51% |
| Dec 29, 2022 | 357.18B | -24.01% |
| Dec 30, 2021 | 470.05B | -43.25% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Proteina | 415.48B |
| SillaJen | 363.01B |
| Genomictree | 297.67B |
| Anterogen.Co.,Ltd. | 264.16B |
| GC Cell | 258.17B |
| NeoImmuneTech | 247.66B |
| HLB Therapeutics | 245.76B |
| Helixmith | 233.46B |